Company

Scale Biosciences

QuantumScale single-cell platform; acquired by 10x in 2025-08

Overview

This profile was compiled from the AI training-data column cards (AI for Science); each column's data view is shown below under "Data profile" (in Chinese).

Data profile · AI for Science

Scale Biosciences

QuantumScale 单细胞平台;2025-08 被 10x 收购

数据类型
单细胞转录组

做什么

QuantumScale 单细胞建库平台,属 split-pool 路线,与 parse-biosciences 同类。Ultima 页面提及其参与"100 Million Cell Challenge"[1]。

对 AI 真值数据的供给角色与成本

可为 ultima-genomics 等高通量测序提供大规模单细胞建库。每细胞价格未查到。

被收购

10x-genomics 收购 Scale Biosciences:2025-08-07 签署、2025-08-11 完成。按 10x 披露,预付款口径约 $3,000 万(现金约 $920 万 + 约 $1,350 万 A 类股,文件拆分口径),技术转移后另付 $2,000 万,另有最高 $3,000 万里程碑;按资产收购处理。$2,000 万是否已支付未验证 ⚠️ [2][3]。

争议与口径冲突

  • 10x 与 Scale、parse-biosciences 之间的专利争议判决未核到一手文件 ⚠️。
  • 成立时间、融资、客户未查到。
  1. https://ultimagenomics.com/focus-areas/single-cell-sequencing (2026-10-15)
  2. https://investors.10xgenomics.com/news/news-details/2025/10x-Genomics-to-Acquire-Scale-Biosciences/ (2026-10-15)
  3. https://www.sec.gov/Archives/edgar/data/1770787/000162828025050332/txg-20250930.htm (2026-10-15)
Last compiled: 2026-10-15